#rare disease

Intellia's Gene Editing Treatment Shows Significant Promise for Hereditary Angioedema

Recent trial results indicate that a single dose of Intellia's CRISPR treatment can significantly reduce swelling attacks in patients with hereditary angioedema, raising interest in one-time therapies.